Vaccine Maker Launches Trial For Combined Influenza, COVID-19 Shot

Reuters (9/8, Roy) reports vaccine developer Novavax “said on Wednesday it has initiated an early-stage study” of its combined flu and COVID-19 vaccine in Australia. The 640 participants are “healthy adults between the ages of 50 and 70 years,” who “will...